REsp 2037059 - ACORDAO

ACÓRDÃO Vistos e relatados estes autos em que são partes as acima indicadas, acordam os Ministros da QUARTA TURMA do Superior Tribunal de Justiça, em sessão virtual de 16/04/2024 a 22/04/2024, por unanimidade, negar provimento ao recurso, nos termos do voto do Sr. Ministro Relator. Os Srs. Ministros Raul Araújo,...

Source-derived case information.

Parties: Agravante: POSTAL SAUDE - CAIXA DE ASSISTENCIA E SAUDE DOS EMPREGADOS DOS CORREIOS
Court: Superior Tribunal de Justiça
Jurisdiction: Brazil
Judgment Date: 24 April 2024
Procedural Posture: Agravo Interno No Recurso Especial / Julgamento Colegiado Quarta Turma (negado Provimento)
Legal Topics: Fornecimento De Medicamento Antineoplásico, Rol Da ANS, Dano Moral, Súmula 7 Do STJ, Off Label, Registro Na ANVISA

Planos De Saúde Direito Civil Direito Da Saúde Fornecimento De Medicamento Antineoplásico Rol Da ANS Dano Moral Súmula 7 Do STJ Off Label +1 more

Source-derived case record

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Party arguments 1

Parties

POSTAL SAUDE - CAIXA DE ASSISTENCIA E SAUDE DOS EMPREGADOS DOS CORREIOS

Agravante

Procedural Posture

Agravo Interno No Recurso Especial / Julgamento Colegiado Quarta Turma (negado Provimento)

Legal Issues

1 Natureza taxativa ou exemplificativa do rol da ANS
2 Obrigação de custeio de fármacos antineoplásicos por plano de saúde
3 Abusividade da recusa de cobertura de medicamento registrado na ANVISA e prescrito pelo médico

About this LexChat collection

Publisher and coverage

LexChat is published by Esheria. Coverage reflects the case law currently mapped from identified source collections; it may be incomplete, delayed, or later corrected. The official source controls where it differs from this research page.

AI and research method

Source-derived facts are shown separately from AI-generated material. If an AI summary is available, it is explicitly labelled and remains a non-authoritative research aid.

Corrections and reporting

Report a source mismatch, factual issue, personal-data concern, or licensing question to support@esheria.co.ke. Include this page's URL and the supporting official source so the record can be reviewed, corrected, restricted, or withdrawn.

Legal-information disclaimer

LexChat provides legal information and research tools, not legal advice. Verify currency, status, citations, and jurisdiction with authoritative sources and a qualified professional where appropriate.